Coupling of Alkyl Iodides and Chiral N-Acylhydrazones
(4S,2′S)-3-(2′-Butanamino)-4-phenylmethyl-2-oxazolidinone
(4S). From (S)-3-(propylidene)amino-4-phenylmethyl-2-oxazolidi-
none (76 mg, 0.33 mmol) and iodomethane (0.41 mL, 6.54 mmol)
by general procedure B and workup A was obtained 4S (39 mg,
(4S,3′R)-3-(5′-Methyl-3′-hexanamino)-4-phenylmethyl-2-ox-
azolidinone (8R). From (S)-3-(propylidene)amino-4-phenylmethyl-
2-oxazolidinone (74 mg, 0.32 mmol) and isobutyl iodide (0.74 mL,
6.4 mmol) by general procedure B and workup B was obtained 8R
(50 mg, 54%; S,R/S,S ) 95:5, NMR analysis) as a colorless oil:
26
48%; S,S/S,R ) 95:5, HPLC analysis) as a colorless oil: [R]D
25
+49.2 (c 0.65, CHCl3); IR (film) 3288, 3028, 2966, 2877, 1758,
1498, 1454, 1399, 1218, 1088 cm-1; 1H NMR (500 MHz, CDCl3)
δ 7.32 (dd, J ) 7.1, 7.1 Hz, 2H), 7.25 (dd, J ) 7.2, 7.2 Hz, 1H),
7.16 (d, J ) 7.0 Hz, 2H), 4.15 (dd, J ) 8.3, 8.3 Hz, 1H), 4.03 (dd,
J ) 8.8, 5.3 Hz, 1H), 3.93-3.88 (m, 1H), 4.30-3.70 (brs, 1H),
3.33 (dd, J ) 13.5, 3.6 Hz, 1H), 3.19-3.10 (m, 1H), 2.62 (dd, J )
13.4, 9.9 Hz, 1H), 1.60-1.57 (m, 1H), 1.41-1.32 (m, 1H), 1.08
(d, J ) 6.4 Hz, 3H), 0.95 (dd, J ) 7.5 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 158.8, 136.0, 129.1, 128.8, 127.0, 66.0, 59.7, 56.0,
37.3, 27.5, 18.0, 9.7; MS (CI) m/z (relative intensity) 249 ([M +
H]+, 100%). Anal. Calcd for C14H20N2O2: C, 67.71; H, 8.12; N,
11.28. Found: C, 67.79; H, 8.09; N, 11.22.
[R]D +19.5 (c 0.85, CHCl3); IR (film) 3299, 3028, 2958, 2872,
1
1758, 1497, 1454, 1399, 1238, 1091, 1030 cm-1; H NMR (500
MHz, CDCl3) δ 7.32 (dd, J ) 7.6, 7.6 Hz, 2H), 7.25 (dd, J ) 7.4,
7.4 Hz, 1H), 7.16 (d, J ) 7.0 Hz, 2H), 4.14 (dd, J ) 8.2, 8.2 Hz,
1H), 4.03 (dd, J ) 8.9, 4.4 Hz, 1H), 3.92-3.87 (m, 1H), 3.97 (br
s, 1H), 3.35 (dd, J ) 13.5, 3.4 Hz, 1H), 3.12-3.03 (m, 1H), 2.60
(dd, J ) 13.4, 10.1 Hz, 1H), 1.82-1.73 (m, 1H), 1.58-1.42 (m,
2H), 1.29 (dd, J ) 6.9, 6.9 Hz, 2H), 0.99-0.94 (m, 9H); 13C NMR
(125 MHz, CDCl3) δ 158.5, 136.1, 129.1, 128.9, 127.0, 65.6, 60.1,
58.4, 41.1, 36.8, 25.4, 24.9, 23.1, 22.7, 8.9; MS (CI) m/z (relative
intensity) 291 ([M + H]+, 100%). Anal. Calcd for C17H26N2O2:
C, 70.31; H, 9.02; N, 9.65. Found: C, 70.21; H, 8.97; N, 9.55.
(4S,3′R)-3-(2′-Methyl-3′-pentanamino)-4-phenylmethyl-2-ox-
azolidinone (9R). From (S)-3-(propylidene)amino-4-phenylmethyl-
2-oxazolidinone (54 mg, 0.23 mmol) and 2-iodopropane (0.24 mL,
2.3 mmol) by general procedure B and workup B was obtained
9R12 (48 mg, 75%; S,R/S,S ) 95:5, NMR analysis) as a colorless
solid.
(4S,3′R)-3-(3′-Hexanamino)-4-phenylmethyl-2-oxazolidi-
none (5R). From (S)-3-(propylidene)amino-4-phenylmethyl-2-ox-
azolidinone (50 mg, 0.22 mmol) and 1-iodopropane (0.21 mL, 2.16
mmol) by general procedure B and workup B was obtained 5R
(39 mg, 66%; S,R/S,S ) 94:6, HPLC analysis) as a colorless oil:
26
[R]D +31.6 (c 1.5, CHCl3); IR (film) 3292, 3063, 3028, 2960,
1
2873, 1758, 1454, 1399, 1238, 1090, 1029 cm-1; H NMR (500
(4S,2′R)-3-(1′-Chloro-2′-butanamino)-4-phenylmethyl-2-ox-
azolidinone (10R). From (S)-3-(propylidene)amino-4-phenyl-
methyl-2-oxazolidinone (50 mg, 0.22 mmol) and chloroiodomethane
(0.16 mL, 2.16 mmol) by general procedure B and workup B was
obtained 10R (38 mg, 63%; S,R/S,S ) 93:7, HPLC analysis) as a
MHz, CDCl3) δ 7.23 (dd, J ) 6.8, 6.8 Hz, 2H), 7.25 (dd, J ) 7.2,
7.2 Hz, 1H), 7.16 (d, J ) 7.5 Hz, 2H), 4.14 (dd, J ) 8.2, 8.2 Hz,
1H), 4.03 (dd, J ) 8.8, 4.6 Hz, 1H), 3.93-3.88 (m, 1H), 3.95 (br
s, 1H), 3.34 (dd, J ) 13.4, 3.5 Hz, 1H), 3.05-2.97 (m, 1H), 2.61
(dd, J ) 13.4, 10 Hz, 1H), 1.54-1.38 (m, 6H), 0.96 (dd, J ) 7.4,
7.4 Hz, 6H); 13C NMR (125 MHz, CDCl3) δ 158.6, 136.0, 129.1,
128.9, 127.0, 65.7, 60.1, 59.9, 36.9, 33.7, 24.8, 18.8, 14.3, 9.0;
MS (CI) m/z (relative intensity) 277 ([M + H]+, 100%), 193 (30%).
Anal. Calcd for C16H24N2O2: C, 69.53; H, 8.75; N, 10.14. Found:
C, 69.46; H, 8.85; N, 10.01.
27
colorless oil: [R]D +44.9 (c 3.4, CHCl3); IR (film) 3286, 3028,
1
2966, 2878, 1758, 1497, 1400, 1240, 1217, 1091, 1207 cm-1; H
NMR (500 MHz, CDCl3) δ 7.31 (dd, J ) 8.0, 8.0 Hz, 2H), 7.25
(dd, J ) 7.9, 7.9 Hz, 1H), 7.16 (d, J ) 7.6 Hz, 2H), 4.13 (dd, J )
8.6, 8.6 Hz, 1H), 4.03 (dd, J ) 8.9, 5.8 Hz, 1H), 3.93-3.88 (m,
1H), 4.25-3.85 (br s, 1H), 3.65 (dd, J ) 11.4, 4.6 Hz, 1H), 3.59
(dd, J ) 11.4, 4.9 Hz, 1H), 3.41 (dd, J ) 13.4, 3.6 Hz, 1H), 3.24
(dddd, J ) 5.5, 5.5, 5.5, 5.5 Hz, 1H), 2.63 (dd, J ) 13.3, 10.1 Hz,
1H), 1.70-1.56 (m, 2H), 1.01 (dd, J ) 7.4, 7.4 Hz, 3H); 13C NMR
(125 MHz, CDCl3) δ 159.0, 135.8, 129.0, 128.9, 127.1, 66.2, 61.3,
59.7, 45.5, 37.1, 23.4, 9.8; MS (CI) m/z (relative intensity) 283
([M + H]+, 100%). Anal. Calcd for C14H19N2O2Cl: C, 59.47; H,
6.77; N, 9.91. Found: C, 59.69; H, 6.82; N, 9.80.
(4S,3′R)-3-(3′-Heptanamino)-4-phenylmethyl-2-oxazolidi-
none (6R). From (S)-3-(propylidene)amino-4-phenylmethyl-2-ox-
azolidinone (100 mg, 0.43 mmol) and 1-iodobutane (0.49 mL, 4.31
mmol) by general procedure B and workup B was obtained 6R
(98 mg, 78%; S,R/S,S ) 95:5, HPLC analysis) as a colorless oil:
26
[R]D +28.3 (c 2.8, CHCl3); IR (film) 3292, 3028, 2960, 2873,
1
1758, 1498, 1455, 1399, 1217, 1198, 1091 cm-1; H NMR (500
MHz, CDCl3) δ 7.32 (dd, J ) 7.6, 7.6 Hz, 2H), 7.25 (dd, J ) 7.3,
7.3 Hz, 1H), 7.16 (d, J ) 7.0 Hz, 2H), 4.13 (dd, J ) 8.8, 7.7 Hz,
1H), 4.03 (dd, J ) 8.9, 4.6 Hz, 1H), 3.92-3.88 (m, 1H), 4.18-
3.85 (br s, 1H), 3.33 (dd, J ) 13.4, 3.5 Hz, 1H), 3.01 (dddd, J )
5.5, 5.5, 5.5, 5.5 Hz, 1H), 2.61 (dd, J ) 13.4, 10.0 Hz, 1H), 1.55-
1.31 (m, 8H), 0.97-0.91 (m, 6H); 13C NMR (125 MHz, CDCl3) δ
158.7, 136.1, 129.1, 128.9, 127.0, 65.7, 60.3, 59.9, 37.0, 31.2, 27.8,
24.7, 22.9, 14.0, 9.0; MS (EI) m/z (relative intensity) 91 (100%),
117 (80%), 233 (60%), 290 (M+, 8%). Anal. Calcd for C17H26-
N2O2: C, 70.31; H, 9.02; N, 9.65. Found: C, 70.29; H, 9.08; N,
9.72.
(4S,2′R)-3-(2′-Ethyl-pyrrolidin-1-yl)-4-phenylmethyl-2-ox-
azolidinone (11R). From (S)-3-(propylidene)amino-4-phenyl-
methyl-2-oxazolidinone (50 mg, 0.22 mmol) and 1-chloro-3-iodo-
propane (0.23 mL, 2.16 mmol) by general procedure B and workup
B was obtained 11R (31 mg, 52%; S,R/S,S ) 96:4, NMR analysis)
26
as a colorless oil: [R]D +34.6 (c 0.85, CHCl3); IR (film) 3054,
1
3004, 2968, 2875, 1731, 1494, 1415, 1237, 1118, 1016 cm-1; H
NMR (500 MHz, CDCl3) δ 7.32 (dd, J ) 7.1, 7.1 Hz, 2H), 7.25
(dd, J ) 7.3, 7.3 Hz, 1H), 7.17 (d, J ) 7.2 Hz, 2H), 4.14 (dd, J )
8.5, 8.5 Hz, 1H), 4.01-3.92 (m, 2H), 3.60-3.52 (m, 2H), 3.42
(dd, J ) 13.3, 3.6 Hz, 1H), 3.16-3.12 (m, 1H), 2.61 (dd, J )
13.3, 10.4 Hz, 1H), 2.05-1.98 (m, 1H), 1.95-1.86 (m, 1H), 1.82-
1.74 (m, 1H), 1.70-1.62 (m, 1H), 1.47-1.31 (m, 2H), 0.93 (dd, J
) 7.4, 7.4 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 154.7, 136.1,
129.0, 128.8, 126.9, 66.3, 62.5, 60.2, 52.1, 38.8, 28.5, 27.1, 21.7,
10.1; MS (CI) m/z (relative intensity) 275 ([M + H]+, 100%). Anal.
Calcd for C16H22N2O2: C, 70.04; H, 8.08; N, 10.21. Found: C,
70.10; H, 8.11; N, 10.01.
(4S,3′R)-3-(3′-Octanamino)-4-phenylmethyl-2-oxazolidi-
none (7R). From (S)-3-(propylidene)amino-4-phenylmethyl-2-ox-
azolidinone (91 mg, 0.39 mmol) and 1-iodopentane (0.51 mL, 3.92
mmol) by general procedure B and workup B was obtained 7R
(94 mg, 79%; S,R/S,S ) 95:5, HPLC analysis) as a colorless oil:
25
[R]D +23.3 (c 2.2, CHCl3); IR (film) 3293, 3063, 2958, 2931,
1760, 1498, 1455 cm-1;1H NMR (500 MHz, CDCl3) δ 7.32 (dd, J
) 7.6, 7.6 Hz, 2H), 7.25 (dd, J ) 7.4, 7.4 Hz, 1H), 7.16 (d, J )
7.0 Hz, 2H), 4.13 (dd, J ) 8.6, 8.6 Hz, 1H), 4.03 (dd, J ) 8.8, 4.3
Hz, 1H), 3.94-3.85 (m, 1H), 4.30-3.75 (br s, 1H), 3.33 (dd, J )
13.3, 2.5 Hz, 1H), 3.08-2.95 (m, 1H), 2.61 (dd, J ) 13.2, 9.9 Hz,
1H), 1.55-1.25 (m, 10H), 0.95 (dd, J ) 7.2, 7.2 Hz, 3H), 0.90
(dd, J ) 6.8, 6.8 Hz, 3H); 13C NMR (125 MHz, CDCl3) δ 158.7,
136.1, 129.1, 128.9, 127.0, 65.7, 60.3, 59.9, 37.0, 32.1, 31.5, 25.2,
24.7, 22.6, 14.0, 9.0; MS (EI) m/z (relative intensity) 91 (100%),
117 (77%), 304 (M+, 9%). Anal. Calcd for C18H28N2O2: C, 71.02;
H, 9.27; N, 9.20. Found: C, 71.12; H, 9.34; N, 9.04.
(4S,3′R)-3-(7′-Chloro-3′-heptanamino)-4-phenylmethyl-2-ox-
azolidinone (12R). From (S)-3-(propylidene)amino-4-phenyl-
methyl-2-oxazolidinone (75 mg, 0.32 mmol) and 1-chloro-4-iodo-
butane (0.40 mL, 3.23 mmol) by general procedure B and workup
B was obtained 12R (58 mg, 55%; S,R/S,S ) 96:4, HPLC analysis)
26
as a colorless oil: [R]D +34.0 (c 0.6, CHCl3); IR (film) 3291,
3063, 3028, 2960, 2873, 1757, 1454, 1400, 1238, 1090, 1029 cm-1
;
1H NMR (500 MHz, CDCl3) δ 7.32 (dd, J ) 7.0, 7.0 Hz, 2H),
7.26 (dd, J ) 7.3, 7.3 Hz, 1H), 7.16 (d, J ) 6.9 Hz, 2H), 4.14 (dd,
J ) 8.8, 7.7 Hz, 1H), 4.03 (dd, J ) 8.9, 4.8 Hz, 1H), 3.94-3.87
J. Org. Chem, Vol. 71, No. 18, 2006 7025